Eppley B L, Summerlin D J, Prevel C D, Sadove A M
Division of Plastic and Reconstructive Surgery, Indiana University Medical Center, Indianapolis 46202-5200.
Aesthetic Plast Surg. 1994 Fall;18(4):413-6. doi: 10.1007/BF00451350.
Based on previous experimental connective tissue work, the use of a positively charged dextran-based biomaterial in subcutaneous tissue sites was evaluated. After hydration with saline, the biomaterial was injected beneath the abdominal skin in rats. A robust macrophage response was initially seen at 30 days without acute inflammation. By one year postoperatively, extensive intermaterial fibroblast and collagen ingrowth had occurred. No evidence of a foreign-body or chronic inflammatory response was seen. These preliminary findings suggest good tissue compatibility of this biomaterial and suggests that when combined with a biocompatible liquid medium, the potential for development of a bioactive dermal and subcutaneous injectable substance exists.
基于先前的实验性结缔组织研究,对一种带正电荷的葡聚糖基生物材料在皮下组织部位的应用进行了评估。用生理盐水水化后,将该生物材料注射到大鼠腹部皮肤下方。最初在30天时观察到强烈的巨噬细胞反应,且无急性炎症。术后一年,材料间出现广泛的成纤维细胞和胶原长入。未发现异物或慢性炎症反应的迹象。这些初步研究结果表明该生物材料具有良好的组织相容性,并表明当与生物相容性液体介质结合时,存在开发一种具有生物活性的真皮和皮下可注射物质的潜力。